Diorganotin(IV) complexes based on tridentate ONO ligands as potential anticancer agents
作者:Wujiu Jiang、Qiqi Qin、Xiyuan Xiao、Yuxing Tan
DOI:10.1016/j.jinorgbio.2022.111808
日期:2022.7
single-crystal X-ray structural analysis. The antiproliferative activity of all complexes was tested against the cancer cell lines NCI-H460, MCF-7 and HepG2. The diorganotin complex 1c has been shown to be more potent antitumor agents against HepG2 than other complexes and cisplatin. Flow cytometry analysis observation demonstrated that complex 1c mediated cell apoptosis of HepG2 cells and arrested cell cycle in
8个新的二有机锡(IV)配合物( 1a - 2d ),即[XC 6 H 4 (O)C=NN=C( Me )COO]R 2 Sn(CH 3 OH)} n ( 1a , 2a ), [XC 6 H 4 (O)C=NN=C( Me )COO]R 2 Sn(CH 3 OH)} 2 ( 1b , 1c , 1d , 2b ), [XC 6 H 4 (O)C= NN=C( Me )COO]R 2 Sn} 2( 2c , 2d ) (X = H-, p -Me-, p -OH- , p -NO 2 -; R = o -Cl-C 6 H 4 CH 2 - 或o -Me-C 6 H 4 CH 2- ),通过微波“一锅”反应与芳基甲酰肼、丙酮酸和相应的R 2 SnCl 2合成。所有配合物均已通过 FT-IR(傅里叶变换红外光谱)、多核 NMR(1 H、13 C 和119Sn 核磁共振光谱)、HRMS(高分辨率质谱)和单晶